Word

JNANA THERAPEUTICS

Status

Registered

Status Code

700

Status Date

Tuesday, October 3, 2023

Serial Number

90980219

Registration Number

7183804

Registration Date

Tuesday, October 3, 2023

Mark Type

4000

Filing Date

Friday, June 25, 2021

Published for Opposition

Tuesday, November 8, 2022

Trademark Owner History

Jnana Therapeutics Inc. - Original Registrant

Classifications

42 Research, development and consultation related thereto in the medical, pharmaceutical research and biotechnology fields; research and development in the medical fields, namely, small molecule pharmaceuticals; pharmaceutical research and development of pharmaceutical preparations and substances that modulate historically undruggable targets across target classes, namely, solute carrier (SLC) metabolite transporters, transcription factors, signaling scaffolds and phosphatases to treat a range of diseases; pharmaceutical research and development of pharmaceutical preparations and substances that impact key immune pathways

"THERAPEUTICS"

Trademark Events

Oct 3, 2023

Notice Of Registration Confirmation Emailed

Oct 3, 2023

Registered-Principal Register

Sep 1, 2023

Notice Of Acceptance Of Statement Of Use E-Mailed

Aug 31, 2023

Allowed Principal Register - Sou Accepted

Jul 31, 2023

Statement Of Use Processing Complete

Jun 29, 2023

Use Amendment Filed

Jul 31, 2023

Divisional Processing Complete

Jun 29, 2023

Divisional Request Received

Jul 19, 2023

Case Assigned To Intent To Use Paralegal

Jun 29, 2023

Teas Statement Of Use Received

Jun 29, 2023

Teas Request To Divide Received

Jan 3, 2023

Noa E-Mailed - Sou Required From Applicant

Nov 8, 2022

Official Gazette Publication Confirmation E-Mailed

Nov 8, 2022

Published For Opposition

Oct 19, 2022

Notification Of Notice Of Publication E-Mailed

Oct 6, 2022

Approved For Pub - Principal Register

Oct 6, 2022

Examiner's Amendment Entered

Oct 6, 2022

Notification Of Examiners Amendment E-Mailed

Oct 6, 2022

Examiners Amendment E-Mailed

Oct 6, 2022

Examiners Amendment -Written

Oct 1, 2022

Teas/Email Correspondence Entered

Sep 30, 2022

Correspondence Received In Law Office

Sep 30, 2022

Teas Response To Office Action Received

Mar 31, 2022

Notification Of Non-Final Action E-Mailed

Mar 31, 2022

Non-Final Action E-Mailed

Mar 31, 2022

Non-Final Action Written

Mar 17, 2022

Assigned To Examiner

Sep 9, 2021

New Application Office Supplied Data Entered

Jun 29, 2021

New Application Entered